Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. ICRP Glossary‏‎ (267 revisions)
  2. Application of ionising radiation in healthcare‏‎ (98 revisions)
  3. Information for healthcare providers‏‎ (80 revisions)
  4. Information for patients, family members, carers and the public‏‎ (62 revisions)
  5. Guide to Radiological Protection in Healthcare‏‎ (43 revisions)
  6. System Of Radiation Protection Overview‏‎ (43 revisions)
  7. General Information on Radon‏‎ (31 revisions)
  8. Main Page‏‎ (29 revisions)
  9. Application of ionising radiation in healthcare (old)‏‎ (24 revisions)
  10. Information for healthcare providers (old)‏‎ (24 revisions)
  11. Information for patients, family members, carers and the public (old)‏‎ (24 revisions)
  12. Effective dose‏‎ (23 revisions)
  13. Radon For Governments and Employers‏‎ (23 revisions)
  14. Radon For Homeowners and Residents‏‎ (22 revisions)
  15. The System of Radiological Protection‏‎ (21 revisions)
  16. Guide to Radon‏‎ (19 revisions)
  17. Tissue weighting factor‏‎ (17 revisions)
  18. List of ICRP Publications on Radiological Protection in Healthcare‏‎ (16 revisions)
  19. System of radiation protection module 2‏‎ (14 revisions)
  20. ICRP publications‏‎ (14 revisions)
  21. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  22. Equivalent dose‏‎ (11 revisions)
  23. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  24. Absorbed dose‏‎ (9 revisions)
  25. Objectives of Radiological Protection‏‎ (9 revisions)
  26. Air-kerma rate constant‏‎ (9 revisions)
  27. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  28. Effects of Exposure‏‎ (8 revisions)
  29. Prudence‏‎ (8 revisions)
  30. Beneficence‏‎ (8 revisions)
  31. Organ/tissue absorbed dose‏‎ (8 revisions)
  32. Collective effective dose‏‎ (7 revisions)
  33. ICRPædia Guides‏‎ (6 revisions)
  34. Justice‏‎ (6 revisions)
  35. Accelerated fractionation‏‎ (6 revisions)
  36. Linear energy transfer‏‎ (6 revisions)
  37. Exposure Categories and Situations‏‎ (6 revisions)
  38. Investigation level‏‎ (6 revisions)
  39. Alimentary tract‏‎ (6 revisions)
  40. Absorbed fraction‏‎ (5 revisions)
  41. Justification‏‎ (5 revisions)
  42. Protection quantities‏‎ (5 revisions)
  43. Kerma‏‎ (5 revisions)
  44. Types of materials‏‎ (5 revisions)
  45. Radiation weighting factor‏‎ (5 revisions)
  46. Air-kerma, entrance surface‏‎ (5 revisions)
  47. Sources of Radiation Exposure‏‎ (5 revisions)
  48. Quality factor‏‎ (5 revisions)
  49. Dose coefficient‏‎ (5 revisions)
  50. Principle of optimisation‏‎ (5 revisions)
  51. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  52. Bioassay‏‎ (4 revisions)
  53. Calculating Radon Doses‏‎ (4 revisions)
  54. Computed tomography dose index‏‎ (4 revisions)
  55. Direct bioassay‏‎ (4 revisions - redirect page)
  56. Mass median diameter‏‎ (4 revisions)
  57. Alpha decay‏‎ (4 revisions)
  58. Math‏‎ (4 revisions)
  59. Programmed cell death‏‎ (4 revisions)
  60. Effective charge number‏‎ (4 revisions)
  61. Averted dose‏‎ (4 revisions)
  62. Effective half-life‏‎ (4 revisions)
  63. Protective action‏‎ (4 revisions)
  64. Reference Animal and Plant‏‎ (4 revisions)
  65. Kp index‏‎ (4 revisions)
  66. Forbiddenness‏‎ (4 revisions)
  67. Aerodynamic diameter‏‎ (4 revisions)
  68. ICRP‏‎ (4 revisions)
  69. Source-related assessment‏‎ (4 revisions)
  70. Reference bioassay function‏‎ (4 revisions)
  71. Diagnostic reference level‏‎ (4 revisions)
  72. Risk‏‎ (4 revisions)
  73. Senescence‏‎ (4 revisions)
  74. Air-kerma, product‏‎ (4 revisions)
  75. Fractionation sensitivity‏‎ (4 revisions)
  76. Optimisation‏‎ (4 revisions)
  77. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  78. Sievert‏‎ (4 revisions)
  79. Non-maleficence‏‎ (4 revisions)
  80. High linear energy transfer radiation‏‎ (4 revisions)
  81. S coefficient (radiation weighted)‏‎ (4 revisions)
  82. Growth fraction‏‎ (3 revisions)
  83. Organ dose equivalent‏‎ (3 revisions)
  84. Extrathoracic airways‏‎ (3 revisions)
  85. Galactic cosmic radiation‏‎ (3 revisions)
  86. Growth hormone (somatotropin)‏‎ (3 revisions)
  87. ICRP Publication 103‏‎ (3 revisions)
  88. Excretion rate (instantaneous)‏‎ (3 revisions)
  89. Fairness‏‎ (3 revisions)
  90. Absorption‏‎ (3 revisions)
  91. Gamma ray‏‎ (3 revisions)
  92. Recovery‏‎ (3 revisions)
  93. DNA damage signalling‏‎ (3 revisions)
  94. Spread-out Bragg peak‏‎ (3 revisions)
  95. Field-size effect (Volume effect)‏‎ (3 revisions)
  96. Gastrointestinal syndrome‏‎ (3 revisions)
  97. Wisdom‏‎ (3 revisions)
  98. Biomedical research volunteer‏‎ (3 revisions)
  99. Cardiomyopathy‏‎ (3 revisions)
  100. Dose equivalent‏‎ (3 revisions)
  101. Flexible tissues‏‎ (3 revisions)
  102. Guide to the System of Radiological Protection‏‎ (3 revisions)
  103. Autonomy‏‎ (3 revisions)
  104. Dose limit‏‎ (3 revisions)
  105. Target region‏‎ (3 revisions)
  106. Fluence‏‎ (3 revisions)
  107. Constancy test‏‎ (3 revisions)
  108. Dose‏‎ (3 revisions)
  109. Dose limits‏‎ (3 revisions)
  110. Fluoroscopically guided interventions‏‎ (3 revisions)
  111. Annual dose‏‎ (3 revisions)
  112. Potential exposure‏‎ (3 revisions)
  113. DS02‏‎ (3 revisions)
  114. Accountability‏‎ (3 revisions)
  115. X ray‏‎ (3 revisions)
  116. Half-life, physical‏‎ (3 revisions)
  117. Cell death‏‎ (3 revisions)
  118. Contamination‏‎ (3 revisions)
  119. Rigidity threshold‏‎ (3 revisions)
  120. Dose of record (E)‏‎ (3 revisions)
  121. Low Earth orbit‏‎ (3 revisions)
  122. Exponential survival curve‏‎ (3 revisions)
  123. Unsealed source‏‎ (3 revisions)
  124. Xerostomia‏‎ (3 revisions)
  125. Annual limit on intake‏‎ (3 revisions)
  126. Graded approach‏‎ (3 revisions)
  127. Public exposure‏‎ (3 revisions)
  128. Dose per content function‏‎ (3 revisions)
  129. Interphase death‏‎ (3 revisions)
  130. Equity‏‎ (3 revisions)
  131. Test‏‎ (3 revisions)
  132. Fractionation‏‎ (3 revisions)
  133. Uptake‏‎ (3 revisions)
  134. Active (red) bone marrow‏‎ (3 revisions)
  135. Utilitarian ethics‏‎ (3 revisions)
  136. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  137. Operational quantity‏‎ (3 revisions)
  138. Value judgement‏‎ (3 revisions)
  139. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  140. Coster-Kronig transition‏‎ (3 revisions)
  141. Valvular heart disease‏‎ (3 revisions)
  142. Gray‏‎ (3 revisions)
  143. Personal dose equivalent‏‎ (3 revisions)
  144. Principle of justification‏‎ (3 revisions)
  145. Radiofrequency ablation‏‎ (3 revisions)
  146. Emergency preparedness‏‎ (3 revisions)
  147. Absolute risk‏‎ (3 revisions)
  148. Virtue ethics‏‎ (3 revisions)
  149. Auger transition‏‎ (3 revisions)
  150. Bystander effect‏‎ (3 revisions)
  151. Iso-effect plots‏‎ (3 revisions)
  152. Emergency procedures‏‎ (3 revisions)
  153. Lifetime risk estimates‏‎ (3 revisions)
  154. Activity median thermodynamic diameter‏‎ (3 revisions)
  155. Voxel phantom‏‎ (3 revisions)
  156. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  157. Complex tissues‏‎ (3 revisions)
  158. Derived air concentration‏‎ (3 revisions)
  159. Dignity‏‎ (3 revisions)
  160. Isomers‏‎ (3 revisions)
  161. Employer‏‎ (3 revisions)
  162. Exposure to Radon at Home‏‎ (2 revisions)
  163. Transparency‏‎ (2 revisions)
  164. GATA binding protein 2‏‎ (2 revisions)
  165. Waste disposal‏‎ (2 revisions)
  166. Non-targeted effects‏‎ (2 revisions)
  167. Hormones‏‎ (2 revisions)
  168. Authorization‏‎ (2 revisions)
  169. Procedural values‏‎ (2 revisions)
  170. Clonogenic cells‏‎ (2 revisions)
  171. Curie‏‎ (2 revisions)
  172. Reproductive integrity‏‎ (2 revisions)
  173. Safety case‏‎ (2 revisions)
  174. Slow repair‏‎ (2 revisions)
  175. Effect Dose 50‏‎ (2 revisions)
  176. Isotropic geometry‏‎ (2 revisions)
  177. Endogeneous excretion‏‎ (2 revisions)
  178. Lineal energy‏‎ (2 revisions)
  179. Thyroid blocking‏‎ (2 revisions)
  180. Trapped particles‏‎ (2 revisions)
  181. Acute radiation syndrome‏‎ (2 revisions)
  182. Orphan source‏‎ (2 revisions)
  183. Hounsfield unit‏‎ (2 revisions)
  184. Authorized limit‏‎ (2 revisions)
  185. Planned exposure situation‏‎ (2 revisions)
  186. Progenitor cell‏‎ (2 revisions)
  187. Cardiac arrhythmias‏‎ (2 revisions)
  188. Radiation belt‏‎ (2 revisions - redirect page)
  189. Clonogenic survival‏‎ (2 revisions)
  190. Reasonableness‏‎ (2 revisions)
  191. Cytokines‏‎ (2 revisions)
  192. Residual dose‏‎ (2 revisions)
  193. Safety culture‏‎ (2 revisions)
  194. Solar cosmic radiation‏‎ (2 revisions)
  195. Inhalability‏‎ (2 revisions)
  196. Spontaneous fission‏‎ (2 revisions)
  197. Itinerant (radiation) worker‏‎ (2 revisions)
  198. Linear-non-threshold model‏‎ (2 revisions)
  199. Time factor‏‎ (2 revisions)
  200. Myocardial perfusion‏‎ (2 revisions)
  201. Adaptive response‏‎ (2 revisions)
  202. What is Radon?‏‎ (2 revisions)
  203. Alveolar-interstitial region‏‎ (2 revisions)
  204. Autoimmune disease‏‎ (2 revisions)
  205. Platelet-derived growth factor‏‎ (2 revisions)
  206. ICRP Publication 118‏‎ (2 revisions)
  207. Cardiac valve diseases‏‎ (2 revisions)
  208. Radiation modifier‏‎ (2 revisions)
  209. Radiological protection principles‏‎ (2 revisions)
  210. Respiratory protection‏‎ (2 revisions)
  211. Disposal‏‎ (2 revisions)
  212. Scintigraphy‏‎ (2 revisions)
  213. Dose criteria‏‎ (2 revisions)
  214. Solar cycle‏‎ (2 revisions)
  215. Inner bremsstrahlung‏‎ (2 revisions)
  216. Environmental exposure‏‎ (2 revisions)
  217. Systemic model‏‎ (2 revisions)
  218. Linear-quadratic dose response model‏‎ (2 revisions)
  219. Exempt waste‏‎ (2 revisions)
  220. Tissue equivalent material‏‎ (2 revisions)
  221. Myocardial stress test‏‎ (2 revisions)
  222. Oversight‏‎ (2 revisions)
  223. Projected dose‏‎ (2 revisions)
  224. Co-expertise‏‎ (2 revisions)
  225. Radionuclides of natural origin‏‎ (2 revisions)
  226. Connective tissue‏‎ (2 revisions)
  227. Recovery (cellular or tissue)‏‎ (2 revisions)
  228. DRL process‏‎ (2 revisions)
  229. Retrievability‏‎ (2 revisions)
  230. Immune system‏‎ (2 revisions)
  231. Institutional control‏‎ (2 revisions)
  232. Stakeholder‏‎ (2 revisions)
  233. Environmental radiation protection‏‎ (2 revisions)
  234. Tachycardia‏‎ (2 revisions)
  235. Exemption level‏‎ (2 revisions)
  236. Existing exposure situation‏‎ (2 revisions)
  237. Gastroschisis‏‎ (2 revisions)
  238. Worker‏‎ (2 revisions)
  239. Nuclear track detectors‏‎ (2 revisions)
  240. Angiogenesis‏‎ (2 revisions)
  241. Hyperbaric oxygen‏‎ (2 revisions)
  242. Bioturbation‏‎ (2 revisions)
  243. Cardioverter-defibrillator‏‎ (2 revisions)
  244. Radiation safety officer‏‎ (2 revisions)
  245. Radioresponsiveness‏‎ (2 revisions)
  246. Consequential late effects‏‎ (2 revisions)
  247. Recovery responder‏‎ (2 revisions)
  248. Reversibility‏‎ (2 revisions)
  249. In vivo radiobioassay‏‎ (2 revisions)
  250. Solar particle event‏‎ (2 revisions)
  251. Effective dose equivalent‏‎ (2 revisions)
  252. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  253. Acceptance test‏‎ (2 revisions)
  254. Gastrulation‏‎ (2 revisions)
  255. Working level‏‎ (2 revisions)
  256. OLINDA/EXM‏‎ (2 revisions)
  257. Habitual mouth breather‏‎ (2 revisions)
  258. Annihilation photons‏‎ (2 revisions)
  259. Particle radiance‏‎ (2 revisions)
  260. Hyperfractionation‏‎ (2 revisions)
  261. Bone marrow‏‎ (2 revisions)
  262. Protection strategy‏‎ (2 revisions)
  263. Radiation source‏‎ (2 revisions)
  264. Cohort study‏‎ (2 revisions)
  265. Radiosensitiser‏‎ (2 revisions)
  266. DRL value‏‎ (2 revisions)
  267. Rehabilitation of living conditions‏‎ (2 revisions)
  268. Right to know‏‎ (2 revisions)
  269. Incidence‏‎ (2 revisions)
  270. Solar wind‏‎ (2 revisions)
  271. Epithelium‏‎ (2 revisions)
  272. Target tissue‏‎ (2 revisions)
  273. Expanded and aligned radiation field‏‎ (2 revisions)
  274. Tolerability‏‎ (2 revisions)
  275. Medical exposure‏‎ (2 revisions)
  276. Naturally occurring radioactive material‏‎ (2 revisions)
  277. Adventitious‏‎ (2 revisions)
  278. Working level month‏‎ (2 revisions)
  279. Habitual nose breather‏‎ (2 revisions)
  280. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  281. Background dose (rate)‏‎ (2 revisions)
  282. Radiosensitivity, cellular‏‎ (2 revisions)
  283. Containment‏‎ (2 revisions)
  284. Rigidity‏‎ (2 revisions)
  285. Dose-length product‏‎ (2 revisions)
  286. Security‏‎ (2 revisions)
  287. Incident‏‎ (2 revisions)
  288. Intermediate level waste‏‎ (2 revisions)
  289. Stenosis‏‎ (2 revisions)
  290. Equieffective dose‏‎ (2 revisions)
  291. Local DRL‏‎ (2 revisions)
  292. Member of the public‏‎ (2 revisions)
  293. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  294. Unattached fraction‏‎ (2 revisions)
  295. Necrosis‏‎ (2 revisions)
  296. Patient entrance reference point‏‎ (2 revisions)
  297. Hypoplasia‏‎ (2 revisions)
  298. Backscatter detection system‏‎ (2 revisions)
  299. Potential recoverability correction factor‏‎ (2 revisions)
  300. Bradycardia‏‎ (2 revisions)
  301. Protective action guide‏‎ (2 revisions)
  302. Radiation worker‏‎ (2 revisions)
  303. Detriment‏‎ (2 revisions)
  304. Dose-rate effect‏‎ (2 revisions)
  305. Inclusiveness‏‎ (2 revisions)
  306. Source-related‏‎ (2 revisions)
  307. Internal conversion electron‏‎ (2 revisions)
  308. Electron-capture decay‏‎ (2 revisions)
  309. LD 50/30‏‎ (2 revisions)
  310. Telangiectasia‏‎ (2 revisions)
  311. Track structure‏‎ (2 revisions)
  312. Mendelian diseases‏‎ (2 revisions)
  313. Accreditation‏‎ (2 revisions)
  314. Neurological syndrome‏‎ (2 revisions)
  315. Genomic integrity‏‎ (2 revisions)
  316. Occupational exposure‏‎ (2 revisions)
  317. Hazard‏‎ (2 revisions)
  318. Peak skin dose‏‎ (2 revisions)
  319. Bragg peak‏‎ (2 revisions)
  320. Radioactive dispersion device‏‎ (2 revisions)
  321. Radon: Units of Measure‏‎ (2 revisions)
  322. Coronary heart disease‏‎ (2 revisions)
  323. Reference air kerma‏‎ (2 revisions)
  324. Decay constant‏‎ (2 revisions)
  325. Self-help protection‏‎ (2 revisions)
  326. Individual-related‏‎ (2 revisions)
  327. Dose of record Hp (10)‏‎ (2 revisions)
  328. Electrophysiology‏‎ (2 revisions)
  329. Storage‏‎ (2 revisions)
  330. Transfer compartment‏‎ (2 revisions)
  331. Mitigation‏‎ (2 revisions)
  332. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  333. Action Level‏‎ (2 revisions)
  334. Upper reference levels‏‎ (2 revisions)
  335. Neurovascular syndrome‏‎ (2 revisions)
  336. Health Surveillance‏‎ (2 revisions)
  337. Pelagic‏‎ (2 revisions)
  338. Basal cell‏‎ (2 revisions)
  339. Practical radiological protection culture‏‎ (2 revisions)
  340. Branching fraction‏‎ (2 revisions)
  341. Chronic exposure‏‎ (2 revisions)
  342. Radioactive source‏‎ (2 revisions)
  343. Colony‏‎ (2 revisions)
  344. Cosmic Radiation in Aviation‏‎ (2 revisions)
  345. Decommissioning‏‎ (2 revisions)
  346. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  347. Dose-threshold‏‎ (2 revisions)
  348. Individual decontamination‏‎ (2 revisions)
  349. Subcutaneous tissue‏‎ (2 revisions)
  350. Low dose rate‏‎ (2 revisions)
  351. Exposure, external or internal‏‎ (2 revisions)
  352. Graft vs host disease‏‎ (2 revisions)
  353. Air-kerma, incident‏‎ (2 revisions)
  354. Heliosphere‏‎ (2 revisions)
  355. Qualified expert‏‎ (2 revisions)
  356. Class SR-0 gases‏‎ (2 revisions)
  357. Radioactive substance‏‎ (2 revisions)
  358. Reference biokinetic model‏‎ (2 revisions)
  359. Decontamination‏‎ (2 revisions)
  360. Relocation‏‎ (2 revisions)
  361. Diastasis‏‎ (2 revisions)
  362. Risk coefficient‏‎ (2 revisions)
  363. Individual monitoring‏‎ (2 revisions)
  364. Dose per unit intake coefficient‏‎ (2 revisions)
  365. Source term‏‎ (2 revisions)
  366. Emergency‏‎ (2 revisions)
  367. Latent time/period or latency interval‏‎ (2 revisions)
  368. Low level waste‏‎ (2 revisions)
  369. Exposure (in the context of inhalation)‏‎ (2 revisions)
  370. Transfer rate‏‎ (2 revisions)
  371. Multi-detector computed tomography‏‎ (2 revisions)
  372. Fractionation and dose delivery patterns‏‎ (2 revisions)
  373. Percutaneous coronary intervention‏‎ (2 revisions)
  374. Prevailing circumstances‏‎ (2 revisions)
  375. Broad beam therapy irradiation technique‏‎ (2 revisions)
  376. Class SR-1 gases‏‎ (2 revisions)
  377. Committed effective dose‏‎ (2 revisions)
  378. Radon Recommendations for Authorities‏‎ (2 revisions)
  379. Cost-benefit analysis‏‎ (2 revisions)
  380. Reference individual‏‎ (2 revisions)
  381. Decontamination factor‏‎ (2 revisions)
  382. Remedial action‏‎ (2 revisions)
  383. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  384. Dose rate‏‎ (2 revisions)
  385. Intervention Level‏‎ (2 revisions)
  386. Emergency exposure situation‏‎ (2 revisions)
  387. Substantial radiation dose level‏‎ (2 revisions)
  388. Erythropoietin‏‎ (2 revisions)
  389. ALARA‏‎ (2 revisions)
  390. Transforming growth factor‏‎ (2 revisions)
  391. Hierarchical tissues‏‎ (2 revisions)
  392. Area monitoring‏‎ (2 revisions)
  393. Pericarditis‏‎ (2 revisions)
  394. Benthic‏‎ (2 revisions)
  395. Principle of application of dose limits‏‎ (2 revisions)
  396. Bronchial region‏‎ (2 revisions)
  397. Class SR-2 gases‏‎ (2 revisions)
  398. Radioactivity‏‎ (2 revisions)
  399. Committed equivalent dose‏‎ (2 revisions)
  400. Radon Recommendations for Workplaces‏‎ (2 revisions)
  401. Reference level‏‎ (2 revisions)
  402. Remediation‏‎ (2 revisions)
  403. Dichotomous‏‎ (2 revisions)
  404. Risk of Exposure to Radon‏‎ (2 revisions)
  405. Dose rate effectiveness factor‏‎ (2 revisions)
  406. South Atlantic anomaly‏‎ (2 revisions)
  407. Interventional procedure‏‎ (2 revisions)
  408. Emergency plan‏‎ (2 revisions)
  409. Ethics‏‎ (2 revisions)
  410. Lymphatic system‏‎ (2 revisions)
  411. Multiplicative risk projection model‏‎ (2 revisions)
  412. Activity‏‎ (2 revisions)
  413. High level waste‏‎ (2 revisions)
  414. Clearance‏‎ (2 revisions)
  415. Deontological Ethics‏‎ (2 revisions)
  416. Repopulation‏‎ (2 revisions)
  417. Differentiation‏‎ (2 revisions)
  418. Routine monitoring‏‎ (2 revisions)
  419. ICRPædia Guide to Radon‏‎ (2 revisions)
  420. Special (non-routine) monitoring‏‎ (2 revisions)
  421. Lifetime risk‏‎ (2 revisions)
  422. Macrophage colony stimulating factor‏‎ (2 revisions)
  423. Beta-minus decay‏‎ (2 revisions)
  424. Clearance level‏‎ (2 revisions)
  425. Radiographer‏‎ (2 revisions)
  426. Representative organism (non-human biota)‏‎ (2 revisions)
  427. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  428. Dose constraint‏‎ (2 revisions)
  429. Early normal tissue responses‏‎ (2 revisions)
  430. Threshold dose for tissue reactions‏‎ (2 revisions)
  431. Magnetosphere‏‎ (2 revisions)
  432. Exposure situation‏‎ (2 revisions)
  433. Transmission detection system‏‎ (2 revisions)
  434. Multistage tumorigenesis‏‎ (2 revisions)
  435. Non-sphericity parameter‏‎ (2 revisions)
  436. Growth factor‏‎ (2 revisions)
  437. Alimentary tract transfer factor‏‎ (2 revisions)
  438. Pharynx‏‎ (2 revisions)
  439. Beta-plus decay‏‎ (2 revisions)
  440. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  441. Cumulative dose‏‎ (2 revisions)
  442. Representative person‏‎ (2 revisions)
  443. Safety‏‎ (2 revisions)
  444. Dose conversion coefficient‏‎ (2 revisions)
  445. Edema‏‎ (2 revisions)
  446. Specific effective energy‏‎ (2 revisions)
  447. Limitation of dose‏‎ (2 revisions)
  448. Excess relative risk‏‎ (2 revisions)
  449. Marrow cellularity‏‎ (1 revision)
  450. Multitarget equation‏‎ (1 revision)
  451. Acute exposure‏‎ (1 revision)
  452. Allometry‏‎ (1 revision)
  453. Pilomatricoma‏‎ (1 revision)
  454. ICRP Publication 102‏‎ (1 revision)
  455. ICRP Publication 116‏‎ (1 revision)
  456. Radiation-induced secondary malignancy‏‎ (1 revision)
  457. ICRP Publication 130‏‎ (1 revision)
  458. Radiological attack‏‎ (1 revision)
  459. ICRP Publication 145‏‎ (1 revision)
  460. Reactive oxygen species‏‎ (1 revision)
  461. ICRP Publication 2‏‎ (1 revision)
  462. Reference worker‏‎ (1 revision)
  463. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  464. Derived consideration reference level‏‎ (1 revision)
  465. ICRP Publication 92‏‎ (1 revision)
  466. ICRP Publication 40‏‎ (1 revision)
  467. ICRP Publication 55‏‎ (1 revision)
  468. Dose conversion convention‏‎ (1 revision)
  469. Informed consent‏‎ (1 revision)
  470. ICRP Publication 7‏‎ (1 revision)
  471. Spongiosa‏‎ (1 revision)
  472. ICRP Publication 84‏‎ (1 revision)
  473. Exclusion‏‎ (1 revision)
  474. Time-resolved computed tomography‏‎ (1 revision)
  475. Mutation component‏‎ (1 revision)
  476. Waste management‏‎ (1 revision)
  477. Normal tissue complication probability‏‎ (1 revision)
  478. Biological half-life‏‎ (1 revision)
  479. ICRP Publication 117‏‎ (1 revision)
  480. ICRP Publication 131‏‎ (1 revision)
  481. Radiological controlled area‏‎ (1 revision)
  482. ICRP Publication 146‏‎ (1 revision)
  483. Concentration ratio‏‎ (1 revision)
  484. ICRP Publication 20‏‎ (1 revision)
  485. Referrer‏‎ (1 revision)
  486. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  487. Derived investigation level‏‎ (1 revision)
  488. ICRP Publication 93‏‎ (1 revision)
  489. ICRP Publication 41‏‎ (1 revision)
  490. Directional dose equivalent‏‎ (1 revision)
  491. ICRU 4-element tissue‏‎ (1 revision)
  492. ICRP Publication 56‏‎ (1 revision)
  493. Dose conversion factor‏‎ (1 revision)
  494. ICRP Publication 70‏‎ (1 revision)
  495. Effect modifier‏‎ (1 revision)
  496. ICRP Publication 85‏‎ (1 revision)
  497. Endosteum‏‎ (1 revision)
  498. System of radiological protection‏‎ (1 revision)
  499. Treatment preparation in radiotherapy‏‎ (1 revision)
  500. Notification value‏‎ (1 revision)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)